Watch Ticker

MERCK KGAA SPNS/ADR

Go to MERCK KGAA SPNS/ADR Website

$24.84

0.00 (0.00%)

Live

Previous Close

$24.8425

Day Range

$0 - $0

Previous Day Range

$24.8 - $25.07

Market Cap

$ USD

Day Vol.

Previous Day Vol.

70042

Currency

USD

Primary Exchange

None

MERCK KGAA SPNS/ADR...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

Springworks Therapeutics - European Commission Grants Conditional Approval of EZMEKLY® (mirdametinib) for the Treatment of Adult and Pediatric Patients with NF1-PN

The European Commission granted conditional marketing authorization for EZMEKLY (mirdametinib), the first therapy approved in the EU for treating symptomatic, inoperable plexiform neurofibromas in adults and children with neurofibromatosis type 1 aged 2 years and above.

Related tickers: MKKGY.

Read Full Article

Towards Healthcare - CRISPR Gene Editing Market Surges USD 4.77 in 2025, `Vertex’s Casgevy, AI-Powered OpenCRISPR-1 and Trisomy 21 Breakthrough Fuels Growth

The global CRISPR gene editing market is projected to grow from USD 4.15 billion in 2024 to USD 16.47 billion by 2034, driven by technological advancements, increasing investments, and growing applications in biotechnology and healthcare.

Related tickers: RVTY, DHR, MKKGY, TMO.

Read Full Article

Trending Tickers

Please sign in to view